Latest news
Tarsus Strikes Up to $800M Deal for Alkeus, Entering Heated Stargardt Disease Race - finance.biggo.comfinance.biggo.com · Fri, 07 Aug 2026 18:41:00 GMTTarsus joins Stargardt race to market with $800m Alkeus takeover - Pharmaceutical TechnologyPharmaceutical Technology · Fri, 07 Aug 2026 13:43:10 GMTTarsus Bets Up To $800M On Alkeus In Retina Therapy Push - Law360Law360 · Thu, 06 Aug 2026 20:43:00 GMTTarsus to purchase Alkeus Pharmaceuticals - Glance by Eyes On EyecareGlance by Eyes On Eyecare · Thu, 06 Aug 2026 19:19:22 GMTAlkeus, an unorthodox eye drug startup, acquired by Tarsus for up to $800M - BioPharma DiveBioPharma Dive · Thu, 06 Aug 2026 19:14:51 GMTAdding to its retina repertoire, Tarsus buys Alkeus in $800M deal - FirstWord PHARMAFirstWord PHARMA · Thu, 06 Aug 2026 18:11:57 GMTTarsus Pharmaceuticals to Acquire Alkeus Pharmaceuticals - Eyewire+Eyewire+ · Thu, 06 Aug 2026 15:47:52 GMTTarsus places $800m wager on Alkeus' Stargardt therapy - pharmaphorumpharmaphorum · Thu, 06 Aug 2026 15:06:32 GMT